除細動器市場規模、シェア、成長分析、タイプ別、患者タイプ別、エンドユーザー別、地域別 - 産業予測、2025-2032年

除細動器2023年の市場規模は151億米ドルで、予測期間（2025-2032年）のCAGRは8.1%で、2024年の163億2,000万米ドルから2032年には304億4,000万米ドルに成長する見通しです。

心臓デバイス市場の成長は、技術の進歩、突然の心停止の発生件数の増加、一般市民の意識の高まり、政府やヘルスケア機関の取り組みによって促進されています。特に、Rapid Response Revival Research Ltd.は、初の家庭用パーソナル自動体外式除細動器（AED）であるCellAEDのCE認証を取得し、同社の拡大戦略に合致しています。治療の進歩にもかかわらず、突然の心停止は依然として心血管系死亡の主な原因であり、植え込み型除細動器（ICD）や体外式AEDの技術革新と需要を促進しています。Ami Italiaのような企業は汎用性の高い除細動器を幅広く提供しており、Microportは中国の心臓リズム管理分野のリーダーとして台頭し、2022年上半期に95%の収益増加を報告しています。ドバイのAED配布・訓練プログラムなどの取り組みに後押しされた新興国市場での認知度の高まりは、市場の継続的成長を約束しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 技術分析
• ケーススタディ
• 特許分析

除細動器市場規模：タイプ別

• 市場概要
• 植込み型除細動器
  • 経静脈植込み型除細動器
  • 皮下植込み型除細動器
• 体外式除細動器
  • 手動および半自動体外除細動器
  • 全自動体外除細動器
  • ウェアラブル除細動器

除細動器市場規模：患者タイプ別

• 市場概要
• 成人
• 小児

除細動器市場規模：エンドユーザー別

• 市場概要
• 病院、診療所、心臓センター
• 病院前ケア
• パブリックアクセスマーケット
• 在宅ケア
• 代替ケア施設
• その他のエンドユーザー

除細動器市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Koninklijke Philips N.V.（Netherlands）
• ZOLL Medical Corporation（Asahi Kasei）（USA/Japan）
• Nihon Kohden Corporation（Japan）
• Stryker（USA）
• BIOTRONIK SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• Schiller AG（Switzerland）
• Mindray Medical International Ltd.（China）
• Defibtech LLC（USA）
• LivaNova PLC（UK）
• Cardiac Science Corporation（USA）
• Bexen Cardio（Spain）
• Physio-Control Inc.（USA）
• CU Medical Systems Co., Ltd.（South Korea）
• Metrax GmbH（Germany）
• BPL Medical Technologies（India）
• Avive Solutions Inc.（USA）

結論と提言

Defibrillator Market size was valued at USD 15.1 billion in 2023 and is poised to grow from USD 16.32 billion in 2024 to USD 30.44 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The growth of the cardiac device market is fueled by advancements in technology, rising incidences of sudden cardiac arrest, heightened public awareness, and initiatives from government and healthcare organizations. Notably, Rapid Response Revival Research Ltd. received CE certification for CellAED, the first home-use personal AED, aligning with their expansion strategy. Despite treatment advancements, sudden cardiac arrest remains a leading cause of cardiovascular mortality, driving innovation and demand for implantable cardioverter-defibrillators (ICDs) and external AEDs. Companies like Ami Italia offer a range of versatile defibrillators, while Microport has emerged as a leader in China's cardiac rhythm management sector, reporting a 95% revenue increase in H1 2022. Growing awareness in developing markets, bolstered by initiatives such as Dubai's AED distribution and training programs, promises continued market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Defibrillator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Defibrillator Market Segments Analysis

Global Defibrillator Market is segmented by Type, Patients type, End Users and region. Based on Type, the market is segmented into Implantable cardioverter defibrillators and External defibrillators. Based on Patients type, the market is segmented into Adult and Pediatrics. Based on End Users, the market is segmented into Hospitals, Clinics and Cardiac centres, Pre-hospital care settings, Public access markets, Home care settings, Alternate care facilities and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Defibrillator Market

The defibrillator market is significantly driven by the rising prevalence of cardiovascular diseases, including coronary artery disease and cardiac arrest, which pose a major health risk to populations globally. In the United States alone, the CDC reported around 695,000 deaths from cardiovascular diseases in 2021, with coronary artery disease notably increasing the likelihood of sudden cardiac deaths due to arrhythmias. Furthermore, the Coronary Artery Disease Foundation highlighted that approximately 356,000 out-of-hospital cardiac arrests occur annually in the country. Contributing factors such as obesity, hypertension, dyslipidemia, diabetes, and an aging population exacerbate this issue, as older individuals face higher risks of developing serious heart-related conditions and arrhythmias, fueling the demand for defibrillators in healthcare settings.

Restraints in the Defibrillator Market

The defibrillator market faces certain restraints primarily due to the high costs associated with advanced models such as implantable cardioverter defibrillators (ICDs) and other sophisticated devices. These financial constraints can hinder their widespread adoption, especially in areas where healthcare budgets are constrained or insurance coverage is insufficient. As a result, the elevated price of these critical medical devices poses a significant challenge, restraining overall market growth and limiting access for healthcare providers and patients in need of these life-saving technologies. Addressing this cost barrier is essential for fostering greater adoption and improving patient outcomes in various regions.

Market Trends of the Defibrillator Market

The defibrillator market is experiencing a significant surge driven by rapid technological advancements focused on improving device performance and patient outcomes. Innovations such as AI algorithms enhance precision in detecting cardiac rhythms, thereby increasing the likelihood of successful resuscitation. Additionally, the integration of wireless connectivity facilitates remote monitoring and data transmission, allowing healthcare providers to make informed decisions in real-time. User interface enhancements are also making defibrillators more intuitive, thereby reducing the learning curve for operators. As a result, the market is trending towards more sophisticated, user-friendly, and interconnected devices, ultimately contributing to enhanced patient care and overall public health outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Patent Analysis

Global Defibrillator Market Size by Type & CAGR (2025-2032)

• Market Overview
• Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
• External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

Global Defibrillator Market Size by Patients type & CAGR (2025-2032)

• Market Overview
• Adult
• Pediatrics

Global Defibrillator Market Size by End Users & CAGR (2025-2032)

• Market Overview
• Hospitals, Clinics and Cardiac centres
• Pre-hospital care settings
• Public access markets
• Home care settings
• Alternate care facilities
• Other end users

Global Defibrillator Market Size & CAGR (2025-2032)

• North America (Type, Patients type, End Users)
  • US
  • Canada
• Europe (Type, Patients type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Patients type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Patients type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patients type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZOLL Medical Corporation (Asahi Kasei) (USA/Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Defibtech LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bexen Cardio (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Physio-Control Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CU Medical Systems Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrax GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avive Solutions Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations